Gibhard, L.; Coertzen, D.; Reader, J.; van der Watt, M.E.; Birkholtz, L.-M.; Wong, H.N.; Batty, K.T.; Haynes, R.K.; Wiesner, L.
The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside. Pharmaceutics 2021, 13, 2066.
https://doi.org/10.3390/pharmaceutics13122066
AMA Style
Gibhard L, Coertzen D, Reader J, van der Watt ME, Birkholtz L-M, Wong HN, Batty KT, Haynes RK, Wiesner L.
The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside. Pharmaceutics. 2021; 13(12):2066.
https://doi.org/10.3390/pharmaceutics13122066
Chicago/Turabian Style
Gibhard, Liezl, Dina Coertzen, Janette Reader, Mariëtte E. van der Watt, Lyn-Marie Birkholtz, Ho Ning Wong, Kevin T. Batty, Richard K. Haynes, and Lubbe Wiesner.
2021. "The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside" Pharmaceutics 13, no. 12: 2066.
https://doi.org/10.3390/pharmaceutics13122066
APA Style
Gibhard, L., Coertzen, D., Reader, J., van der Watt, M. E., Birkholtz, L.-M., Wong, H. N., Batty, K. T., Haynes, R. K., & Wiesner, L.
(2021). The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside. Pharmaceutics, 13(12), 2066.
https://doi.org/10.3390/pharmaceutics13122066